Clinical Trials Browser

Interventional × Urethral Neoplasms × Sunitinib × Clear all

NCT01089088 2018-10-26

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00397488 2016-01-25

Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium

Phase 2 Completed

78 enrolled 6 charts

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT01118039 2013-08-07

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms, Urethral Neoplasms